Market Overview:
The global pacemakers and cardiac resynchronization therapy devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of heart failure, technological advancements in pacemaker and CRT devices, and rising geriatric population. Based on type, the global pacemakers and CRT devices market is segmented into pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. The ICD segment is expected to account for the largest share of the global market in 2018. This can be attributed to its high usage rates for treating patients with bradycardia or tachycardia disorders. However, the CRT device segment is projected to grow at a higher CAGR during the forecast period owing to its growing use in patients with heart failure. Based on application, the global pacemakers and CRT devices market is divided into bradycardia treatment, tachycardia treatment, heart failure treatment, and other applications such as Atrial Fibrillation (AF) ablation procedures or ventricular assist device (VAD) support therapies .
Product Definition:
Pacemakers are devices that are implanted in the body to help control abnormal heart rhythms. Cardiac resynchronization therapy (CRT) is a type of pacemaker that is used to treat heart failure. CRT helps improve the heart's ability to pump blood by making the left and right ventricles contract together. This improves the efficiency of blood flow throughout the body.
Pacemaker:
A pacemaker is a device that helps the heart to beat at a regular and consistent rate. It does not replace the heart’s natural pumping mechanism, but instead supplements it in case of any defects or if the patient is suffering from cardiac arrhythmia. Pacemakers can be classified into two types: external and internal pacemakers.
ICD:
ICD-10 is an international classification of diseases and health conditions that provides a unique identification number to every person, company, organization or country. It is the 10th revision of ICD-9. The purpose of this classification system is to provide healthcare professionals with a universal language in which they can categorize any disease or condition for data extraction and reporting purposes.
Application Insights:
The bradycardia segment held the largest share of 28.0% in 2017. The growing prevalence of cardiac disorders coupled with a high demand for pacemakers as a treatment method is anticipated to drive the market over the forecast period. Pacemakers are used as an effective and safe therapy for patients suffering from bradyarrhythmia, heart block, and long QT syndrome due to various factors such as advanced technology used in devices, experience gained by healthcare professionals during clinical trials, availability of advanced therapies at affordable costs, etc.
The tachycardia segment is expected to grow at a lucrative rate during the forecast period owing to increasing awareness about early diagnosis and treatment options along with rising incidences of heart diseases among adults which can be treated effectively by implantable cardioverter-defibrillators (ICD).
Regional Analysis:
North America dominated the global pacemakers and cardiac resynchronization therapy devices market in 2017. This can be attributed to favorable reimbursement policies, increasing prevalence of heart failure, and growing awareness about advanced technologies. Moreover, a high number of FDA approvals for various devices is also expected to drive the regional market over the forecast period. The U.S.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising demand for minimally invasive procedures
- Technological advancements in pacemaker and CRT devices
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Pacemakers and Cardiac Resynchronization Therapy Devices Market Research Report
By Type
Pacemaker, ICD, CRT
By Application
Bradycardia, Tachycardia, Heart Failure, Others
By Companies
Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, MicroPort, Medico, Lepu (Qinming Medical), IMZ, Cardioelectronica, Pacetronix
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Report Segments:
The global Pacemakers and Cardiac Resynchronization Therapy Devices market is segmented on the basis of:
Types
Pacemaker, ICD, CRT
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Bradycardia, Tachycardia, Heart Failure, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- St. Jude Medical (Abbott)
- Boston Scientific
- Biotronik
- MicroPort
- Medico
- Lepu (Qinming Medical)
- IMZ
- Cardioelectronica
- Pacetronix
Highlights of The Pacemakers and Cardiac Resynchronization Therapy Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pacemaker
- ICD
- CRT
- By Application:
- Bradycardia
- Tachycardia
- Heart Failure
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pacemakers and Cardiac Resynchronization Therapy Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pacemakers and cardiac resynchronization therapy devices are medical devices that help to maintain the rhythm of the heart. Pacemakers help to regulate the heartbeat by providing a consistent, predictable pulse. Cardiac resynchronization therapy devices help to improve the function of the heart by correcting any abnormalities in its rhythm.
Some of the major companies in the pacemakers and cardiac resynchronization therapy devices market are Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, MicroPort, Medico, Lepu (Qinming Medical), IMZ, Cardioelectronica, Pacetronix.
The pacemakers and cardiac resynchronization therapy devices market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pacemakers and Cardiac Resynchronization Therapy Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pacemakers and Cardiac Resynchronization Therapy Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pacemakers and Cardiac Resynchronization Therapy Devices Market - Supply Chain
4.5. Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Forecast
4.5.1. Pacemakers and Cardiac Resynchronization Therapy Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pacemakers and Cardiac Resynchronization Therapy Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pacemakers and Cardiac Resynchronization Therapy Devices Market Absolute $ Opportunity
5. Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Type
5.3.1. Pacemaker
5.3.2. ICD
5.3.3. CRT
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Application
6.3.1. Bradycardia
6.3.2. Tachycardia
6.3.3. Heart Failure
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pacemakers and Cardiac Resynchronization Therapy Devices Demand Share Forecast, 2019-2029
9. North America Pacemakers and Cardiac Resynchronization Therapy Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Application
9.4.1. Bradycardia
9.4.2. Tachycardia
9.4.3. Heart Failure
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Type
9.7.1. Pacemaker
9.7.2. ICD
9.7.3. CRT
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pacemakers and Cardiac Resynchronization Therapy Devices Demand Share Forecast, 2019-2029
10. Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Application
10.4.1. Bradycardia
10.4.2. Tachycardia
10.4.3. Heart Failure
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Type
10.7.1. Pacemaker
10.7.2. ICD
10.7.3. CRT
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Demand Share Forecast, 2019-2029
11. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Application
11.4.1. Bradycardia
11.4.2. Tachycardia
11.4.3. Heart Failure
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growh Projections by Application
11.7. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Type
11.7.1. Pacemaker
11.7.2. ICD
11.7.3. CRT
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pacemakers and Cardiac Resynchronization Therapy Devices Demand Share, 2019-2029
12. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Application
12.4.1. Bradycardia
12.4.2. Tachycardia
12.4.3. Heart Failure
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Type
12.7.1. Pacemaker
12.7.2. ICD
12.7.3. CRT
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Demand Share, 2019-2029
13. Middle East & Africa Pacemakers and Cardiac Resynchronization Therapy Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Application
13.4.1. Bradycardia
13.4.2. Tachycardia
13.4.3. Heart Failure
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pacemakers and Cardiac Resynchronization Therapy Devices Market Size and Volume Forecast by Type
13.7.1. Pacemaker
13.7.2. ICD
13.7.3. CRT
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pacemakers and Cardiac Resynchronization Therapy Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Pacemakers and Cardiac Resynchronization Therapy Devices Market: Market Share Analysis
14.2. Pacemakers and Cardiac Resynchronization Therapy Devices Distributors and Customers
14.3. Pacemakers and Cardiac Resynchronization Therapy Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. St. Jude Medical (Abbott)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biotronik
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. MicroPort
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Medico
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Lepu (Qinming Medical)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. IMZ
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Cardioelectronica
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Pacetronix
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook